Suppr超能文献

氯苯氧异丁酸酯对线粒体能量转导的抑制模式。

Mode of inhibition of mitochondrial energy transduction by chlorophenoxyisobutyrate.

作者信息

Panini S R, Kurup C K

出版信息

Biochem J. 1974 Aug;142(2):253-61. doi: 10.1042/bj1420253.

Abstract
  1. alpha-p-Chlorophenoxyisobutyric acid, the ethyl ester of which is widely used as an antihypercholesterolaemic drug, is an inhibitor of energy-transfer reactions in isolated rat liver mitochondria. 2. The compound at lower concentrations (<4.0mumol/mg of mitochondrial protein) inhibits state 3 oxidation, stimulates state 4 oxidation, abolishes respiratory control and stimulates the latent adenosine triphosphatase activity of mitochondria. The inhibition imposed on state 3 oxidation is relieved by dinitrophenol. 3. At higher concentrations it inhibits coupled phosphorylation as well as dinitrophenol-stimulated adenosine triphosphatase activity. The inhibition of state 3 oxidation under these conditions is not reversed by uncouplers. 4. The three coupling sites of phosphorylation exhibit differential susceptibility to inactivation by this compound. Coupled phosphorylation at the first site is abolished at a drug concentration of 3.0mumol/mg of protein. The third site is inactivated when the concentration of the drug reaches 5.0mumol/mg of protein. The second site is the most refractory and drug concentrations of the order of 10.0mumol/mg of protein are required effectively to inhibit phosphorylation at this site. 5. The compound also inhibits ATP-dependent reversal of electron transport as well as the adenosine triphosphatase activity in submitochondrial particles. 6. The oxidation of NADH and succinate in these particles is not inhibited. 7. These properties indicate that the compound acts as an ;inhibitory uncoupler' of energy-transfer reactions in isolated mitochondria.
摘要
  1. α-对氯苯氧基异丁酸,其乙酯被广泛用作抗高胆固醇血症药物,是分离的大鼠肝线粒体中能量转移反应的抑制剂。2. 该化合物在较低浓度(<4.0μmol/mg线粒体蛋白)时抑制状态3氧化,刺激状态4氧化,消除呼吸控制并刺激线粒体潜在的腺苷三磷酸酶活性。对状态3氧化的抑制可被二硝基苯酚解除。3. 在较高浓度时,它抑制偶联磷酸化以及二硝基苯酚刺激的腺苷三磷酸酶活性。在这些条件下对状态3氧化的抑制不能被解偶联剂逆转。4. 磷酸化的三个偶联位点对该化合物失活表现出不同的敏感性。当药物浓度为3.0μmol/mg蛋白时,第一个位点的偶联磷酸化被消除。当药物浓度达到5.0μmol/mg蛋白时,第三个位点失活。第二个位点最耐受,需要约10.0μmol/mg蛋白的药物浓度才能有效抑制该位点的磷酸化。5. 该化合物还抑制ATP依赖的电子传递逆转以及亚线粒体颗粒中的腺苷三磷酸酶活性。6. 这些颗粒中NADH和琥珀酸的氧化未被抑制。7. 这些特性表明该化合物在分离的线粒体中作为能量转移反应的“抑制性解偶联剂”起作用。

相似文献

2
Cooperativity in the inhibition of oxidative phosphorylation by chlorophenoxyisobutyrate.
Biochim Biophys Acta. 1974 Oct 18;368(1):29-38. doi: 10.1016/0005-2728(74)90094-2.

本文引用的文献

3
BIOCHEMICAL ASPECTS OF TOXICOLOGY OF ATROMID.
J Atheroscler Res. 1963 Sep-Dec;3:737-9. doi: 10.1016/s0368-1319(63)80060-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验